{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":1320,"summary":"Hosted by Corey with the Story. Stay informed with the latest business, stock market, and finance headlines, updates, and breaking stories delivered daily in quick, engaging episodes. Subscribe! The Daily News Now! — Every city. Every story. AI-powered. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-06-17T18:18:57.837082+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"Pfizer’s Monthly Shot Could Shake Up Weight Loss Market","slug":"pfizer-s-monthly-shot-could-shake-up-weight-loss-market","published_at":"2026-06-12T17:23:41+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/pfizer-s-monthly-shot-could-shake-up-weight-loss-market","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/8eb6d558-41f4-45e0-81ea-407f8bc9b708.mp3","audio_url":"https://api.fastcast.ai/audio/8eb6d558-41f4-45e0-81ea-407f8bc9b708.mp3","summary":"Pfizer is poised to disrupt the booming weight-loss drug market with berobenatide, a once-monthly injection that could outshine weekly shots from Novo Nordisk and Eli Lilly—offering patients greater convenience and potentially better long-term adherence. With the market projected to hit $150 billion by 2035, Pfizer’s multi-trial approach for both weight loss and type 2 diabetes signals serious intent. While current competitors may still edge ahead in early results, Pfizer’s focus on accessibility could shift the game—and force investors to watch closely as the race for dominance heats up. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/d7c155417b83aef1","meta_description":"Pfizer is poised to disrupt the booming weight-loss drug market with berobenatide, a once-monthly injection that could outshine weekly shots from Novo Nor…","key_points":[],"chapters":[],"topics":[],"duration_seconds":115,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/pfizer-s-monthly-shot-could-shake-up-weight-loss-market/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/pfizer-s-monthly-shot-could-shake-up-weight-loss-market.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}